Biomarkers and surrogate endpoints in glaucoma clinical trials. - Wikidata - wikimedia - TriplyDB

Biomarkers and surrogate endpoints in glaucoma clinical trials.

Biomarkers and surrogate endpoints in glaucoma clinical trials.

http://www.wikidata.org/entity/Q35912696

about

Ab interno trabecular bypass surgery with Trabectome for open angle glaucoma Association between progressive retinal nerve fiber layer loss and longitudinal change in quality of life in glaucoma GDF15 is elevated in mice following retinal ganglion cell death and in glaucoma patients Spectral-Domain Optical Coherence Tomography for Glaucoma Diagnosis Frequency Doubling Technology Perimetry and Changes in Quality of Life of Glaucoma Patients: A Longitudinal Study.Network Meta-analysis for Clinical Practice Guidelines: A Case Study on First-Line Medical Therapies for Primary Open-Angle Glaucoma.A window to beyond the orbit: the value of optical coherence tomography in non-ocular disease.Missed opportunity from randomised controlled trials of medical interventions for open-angle glaucoma.Genetic and Biochemical Biomarkers in Canine Glaucoma.Network meta-analysis: an introduction for clinicians.Assessment of the Incorporation of Patient-Centric Outcomes in Studies of Minimally Invasive Glaucoma Surgical Devices.Evaluation of Visual Field and Imaging Outcomes for Glaucoma Clinical Trials (An American Ophthalomological Society Thesis).Association between Intraocular Pressure and Rates of Retinal Nerve Fiber Layer Loss Measured by Optical Coherence Tomography.

P2860

Q26470443-5F11E121-FCEE-4FCE-B90D-26A7310B2B71 Q27344981-184430F1-EFE0-4A0C-A2C8-FB8A55E4CED0 Q33631141-3F764582-BEB3-4FE0-ADF6-A84E4B316317 Q35697738-53BFC0B2-15B0-4109-8E0D-7B8EB9CCC13E Q35733143-29936EC6-70EC-4C3A-8C3C-7D4B214E4BA4 Q35992361-4B3C9324-643F-4AB6-9D64-5E0CE6898B9D Q38709464-9116D576-9226-4EBF-9469-07CC21B6300E Q38922331-21FA0B85-9666-43AF-86FF-ABB184137F4E Q38966980-CEA4D404-F702-4A55-BBB9-473F19CF2222 Q39134420-E779BADF-A5DC-40CA-B136-2F14A914D607 Q40662423-7B522339-1C8B-4ED2-B698-E48CF1775D19 Q43241177-F6583AFB-AC1E-48E2-AF10-BA7075B615A3 Q46720515-0660E5D4-5A1C-4373-933E-1FB940287B36

P2860

Biomarkers and surrogate endpoints in glaucoma clinical trials.

http://www.wikidata.org/entity/Q35912696

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Biomarkers and surrogate endpoints in glaucoma clinical trials.

@ast

Biomarkers and surrogate endpoints in glaucoma clinical trials.

@en

type

label

Biomarkers and surrogate endpoints in glaucoma clinical trials.

@ast

Biomarkers and surrogate endpoints in glaucoma clinical trials.

@en

prefLabel

Biomarkers and surrogate endpoints in glaucoma clinical trials.

@ast

Biomarkers and surrogate endpoints in glaucoma clinical trials.

@en

P1433

Q35912696-4CC35C0F-3EFA-4747-93B6-854B3CC843CC

P1476

Q35912696-C41EE9EC-3124-436A-9241-25FB8B070BC7

P2093

Q35912696-735D92E3-F1FC-40B3-9CF5-59B0ECC6F6C2

P2860

Q35912696-00BD8A87-3EF1-4185-8872-692DF11B4F2E

Q35912696-065F39AC-0345-4270-9BC6-912AB15B861C

Q35912696-06C06266-E098-4508-A232-A350D0A7AF94

Q35912696-09A3EC28-A975-4EC5-80B9-7CED9B8E8569

Q35912696-136C9366-8854-4804-8BEE-4D31AD12DE6E

Q35912696-14C4BBAF-77F5-4179-AA10-999C590C76B6

Q35912696-1BD9BBEB-2B62-4329-A970-50BF7A142A50

Q35912696-1CF0DFB7-6C62-446D-BAB6-794C6E77743D

Q35912696-1FA20A90-1926-4F2D-9620-5C95422F551A

Q35912696-26EBD2A7-459C-4947-85DF-3968BB960FFF

P304

Q35912696-82875639-A520-4B66-94C8-20E716C03A1D

P31

Q35912696-D65921C9-4E4F-4BDD-8079-38B7F19F5849

P356

Q35912696-EE933995-4B84-4389-A1AC-CB995FFD04BB

P407

Q35912696-8E76B9F9-7045-44C9-947D-9163B97F0BB8

P433

Q35912696-A82A47A8-7CEA-4182-8468-41E0F3647A35

P478

Q35912696-9C81F046-2A97-48F0-9B1F-C8E88B5B7818

P577

Q35912696-44CDBF84-545C-4F4D-871C-179441FE414E

P698

Q35912696-82FEB7BC-3C38-4D10-B14E-1CAC6E4D576B

P921

Q35912696-2AAAF62C-2DAA-4D36-A864-ADAF096052A4

P932

Q35912696-6C02992B-E23A-4A59-BB74-79960C4AA2E6

P356

BJOPHTHALMOL-2014-305550

P1433

British Journal of Ophthalmology

P1476

Biomarkers and surrogate endpoints in glaucoma clinical trials.

@en

P2093

Felipe A Medeiros

http://www.w3.org/2001/XMLSchema#string

P2860

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

Methodological variations in estimating apparent progressive visual field loss in clinical trials of glaucoma treatment.

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial.

Incidence and rates of visual field progression after longitudinally measured optic disc change in glaucoma.

Prediction of functional loss in glaucoma from progressive optic disc damage

Retinal nerve fibre layer thickness measurement reproducibility improved with spectral domain optical coherence tomography

Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease.

Combining structural and functional measurements to improve detection of glaucoma progression using Bayesian hierarchical models

Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies.

Glaucoma patients' assessment of their visual function and quality of life

P304

599-603

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJOPHTHALMOL-2014-305550

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25034049

http://www.w3.org/2001/XMLSchema#string

P921

P932

4523640

http://www.w3.org/2001/XMLSchema#string